Best Supportive Care
Best Supportive Care is an intervention with 70 clinical trials. Currently 7 active trials ongoing. Historical success rate of 78.8%.
Success Metrics
Based on 41 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
31
Mid Stage
32
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
77.4%
41 of 53 finished
22.6%
12 ended early
7
trials recruiting
70
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Botensilimab + Balstilimab vs Best Supportive Care as Therapy in Chemo-refractory, Unresectable, Colorectal Adenocarcinoma
A Phase II Study of AAA617 Alone and AAA617 in Combination With ARPI in Patients With PSMA PET Scan Positive CRPC
Ravulizumab in Thrombotic Microangiopathy After Hematopoietic Stem Cell Transplant
A Study Evaluating [177Lu]Lu-PSMA-617 vs. a Change of Androgen Receptor-directed Therapy in Taxane Treatment Naive Chinese Male Patients With Progressive Metastatic Castrate Resistant Prostate Cancer
Study of Ravulizumab in Pediatric Participants With HSCT-TMA
Clinical Trials (70)
Botensilimab + Balstilimab vs Best Supportive Care as Therapy in Chemo-refractory, Unresectable, Colorectal Adenocarcinoma
A Phase II Study of AAA617 Alone and AAA617 in Combination With ARPI in Patients With PSMA PET Scan Positive CRPC
Ravulizumab in Thrombotic Microangiopathy After Hematopoietic Stem Cell Transplant
A Study Evaluating [177Lu]Lu-PSMA-617 vs. a Change of Androgen Receptor-directed Therapy in Taxane Treatment Naive Chinese Male Patients With Progressive Metastatic Castrate Resistant Prostate Cancer
Study of Ravulizumab in Pediatric Participants With HSCT-TMA
A Study of Avelumab in Penile Cancer Who Are Unfit for or Have Progressed After Platinum-Based Chemotherapy
Biliary Drainage Plus HAIC in Locally Advanced pCCA
A Study to Evaluate Neoadjuvant Sonidegib Followed by Surgery or Imiquimod in the Management of Basal Cell Carcinoma
Study of Palliative Radiotherapy for Symptomatic Hepatocellular Carcinoma and Liver Metastases
Ravulizumab in Thrombotic Microangiopathy Associated With a Trigger
A Study of Docetaxel for Injection (Albumin Bound) in Patients With Advanced Pancreatic Cancer
Multicentre Placebo-controlled Double-blinded Phase II Study of Lenvatinib Efficacy in Patients With Locally Advanced or Metastatic GIST (Gastrointestinal Stromal Tumor) After Imatinib/Sunitinib Failure
Prognostic Factors for Survival in Patients With Cholangiocarcinoma
A Study Of Avelumab In Patients With Locally Advanced Or Metastatic Urothelial Cancer (JAVELIN Bladder 100)
The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)
Maintenance Tislelizumab + Capecitabine to Treat Metastatic Colorectal Cancer
Durvalumab and Tremelimumab and Best Supportive Care vs Best Supportive Care in Patients With Advanced Colorectal Cancer
Transanal Irrigation - Best Treatment Possibility for Low Anterior Resection Syndrome? Multicenter, Randomized Clinical Trial
Convalescent Plasma as Treatment for Subjects With Early COVID-19 Infection
BBI608 and Best Supportive Care vs Placebo and Best Supportive Care in Pretreated Advanced Colorectal Carcinoma
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 70